Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    11000253 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
Conditions: HIV;   AIDS
Intervention: Drug: Raltegravir (Isentress®)
2 Completed Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women
Condition: HIV Infections
Intervention:
3 Completed Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers
Condition: Healthy Volunteer
Intervention: Drug: Raltegravir

Indicates status has not been verified in more than two years